AHP 1: Stock rise ignores the fen-phen litigation
May 30,1998 Introduction: After American Home Products withdrew Redux and Pondimin from the market last September, the stock fell. In [...]
AHP 2: Punitive damages awarded in Diet Drug Cases
A summary of four earlier Verdict reports show that AHP had repeatedly underestimated reserves for fen-phen.
AHP 3: Diet drug settlement costs continue to rise
May 24, 2000 1) December 31, 1997: Verdict reported that AHP’s fen-phen exposure exceeded the then current estimates of $3-4 [...]
AHP 4: Fen-phen reservers were consistently low
On 5/27/05 Bloomberg said Wyeth increased fen-phen reserve to $21.1 billion Until AHP releases more data Verdict can not evaluate [...]
AHP 4: Fen-phen reserves were consitently low
As AHP continually changed its litigation reserves for fen-phen, Verdict repeatedly predicted the reserves were inadequate. The final cost was $20 billion.
AHP 5: Fen-phen, The $22 Billion Gold Rush
Forbes Magazine reports the final cost of AHP/Wyeth's fen-fen suits to be $22 billion.
Related Case Type
